← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2005Last known activity
May 19, 2021
Timeline
1990s
- Jan 1, 1998
INC Research— Founded
2000s
- Jul 1, 2009
MDS Pharma— Acquired
2010s
- May 4, 2011
Kendle International Inc.— Acquired
Drugs by trial phase (200 distinct, 248 trials)
Phase 4 (3 own, 6 via acquisition)
Phase 3 (27 own, 8 via acquisition)
Phase 2 (30 own, 10 via acquisition)
Phase 1 (36 own, 75 via acquisition)
Other trials (0 own, 5 via acquisition)
Indications
Studied for
- Acute Disease
- Alzheimer Disease
- Amyotrophic Lateral Sclerosis
- Anemia
- Anemia, Iron-Deficiency
- Anxiety Disorders
- Brain Injuries
- Brain Injuries, Traumatic
- Breast Neoplasms
- Bronchitis
- Bronchitis, Chronic
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Central Nervous System Diseases
- Cerebral Palsy
- Charcot-Marie-Tooth Disease
- Clostridium Infections
- Cognitive Dysfunction
- Colitis
- Colitis, Ulcerative
- Communicable Diseases
- Constipation
- Crohn Disease
- Cystic Fibrosis
- Depression
- Depressive Disorder
- Depressive Disorder, Treatment-Resistant
- Diabetic Foot
- Diabetic Neuropathies
- Disease
- Encephalitis
- Encephalitis, Japanese
- Eunuchism
- Fibromyalgia
- Foot Ulcer
- Heart Failure
- Hematologic Neoplasms
- Hemoglobinopathies
- Hemorrhagic Fever, Ebola
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hereditary Sensory and Motor Neuropathy
- Hypoglycemia
- Hypogonadism
- Hyponatremia
- Immunologic Deficiency Syndromes
- Infections
- Influenza, Human
- Kidney Diseases
- Latent Tuberculosis
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Juvenile
- Lice Infestations
- Lung Neoplasms
- Major Depressive Disorder
- Measles
- Melanoma
- Metabolism, Inborn Errors
- Mite Infestations
- Multiple Sclerosis
- Multiple Sclerosis, Chronic Progressive
- Mumps
- Muscle Spasticity
- Myelodysplastic Syndromes
- Myofascial Pain Syndromes
- Myopia
- Nausea
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Glandular and Epithelial
- Nerve Compression Syndromes
- Nervous System Diseases
- Neuralgia
- Neuralgia, Postherpetic
- Obesity
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Pancytopenia
- Parasitic Diseases
- Parkinson Disease
- Poliomyelitis
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Purpura, Thrombocytopenic, Idiopathic
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Respiratory Tract Diseases
- Respiratory Tract Infections
- Rhinitis
- Rhinitis, Allergic
- RNA Virus Infections
- Rubella
- Schizophrenia
- Sclerosis
- Sleep Initiation and Maintenance Disorders
- Sleep Wake Disorders
- Squamous Cell Carcinoma of Head and Neck
Subsidiaries (2 direct, 3 total across the full acquisition tree)
Recent trials (50)
- NCT04855565CollaboratorPhase 1May 19, 2021
- NCT03156790CollaboratorPhase 2Dec 15, 2017
- NCT03350620CollaboratorPhase 3Nov 20, 2017
- NCT03337126CollaboratorPhase 1Nov 6, 2017
- NCT03337126Overall official - principal investigatorPhase 1Nov 6, 2017
- NCT03099824CollaboratorPhase 1Oct 1, 2017
- NCT03200080Overall official - principal investigatorPhase 1Sep 18, 2017
- NCT03194139CollaboratorPhase 1Sep 1, 2017
- NCT03164109CollaboratorPhase 1Aug 1, 2017
- NCT03051256CollaboratorPhase 2Jul 1, 2017
- NCT02947685CollaboratorPhase 3Jun 30, 2017
- NCT03198728CollaboratorPhase 3Jun 29, 2017
- NCT03198728Study directorPhase 3Jun 29, 2017
- NCT03119662CollaboratorPhase 4Jun 1, 2017
- NCT03152123Overall official - principal investigatorPhase 1Mar 15, 2017
Details
- Founded
- Raleigh, NC, US Jan 1, 1998
- Last known activity
- May 19, 2021